Table 2. Additional data from patients, including scheme of chemotherapy cycles, fasting regimens and tumor response.
* also utilized low glycemic diet for 24 hours prior to fast. ** also utilized liquid diet for 24 hours after fast. n/a = not applicable, due to chemotherapy being administered in the adjuvant setting.
| Cycle# | Fast(hours) | Chemotherapy | Tumor Response | |
| Case 1 | 1 | 140 pre 40 post | Docetaxel 75mg/m2 + Cyclophosphamide 600mg/m2 | n/a |
| 4 | 120 pre 24 post | Docetaxel 75mg/m2 + Cyclophosphamide 600mg/m2 | n/a | |
| Case 2 | 4 | 72 pre 51 post | Docetaxel 64.6mg/m2 + carboplatin 485mg + 5FU 2415.7 mg/m2 | --- |
| 5 | 48 pre 56 post | Docetaxel 79 mg/m2 + carboplatin 470mg + 5FU 2415.7 mg/m2 | Stable disease on CT/PET | |
| 6 | 48 pre 56 post | Docetaxel 79 mg/m2 + carboplatin 470mg + 5FU 2415.7 mg/m2 | Improvement on CT/PET. Refer to text. | |
| 7 | 48 pre 56 post | Docetaxel 79 mg/m2 + carboplatin 470mg + 5FU 2415.7 mg/m2 | --- | |
| 8 | 48 pre 56 post | Docetaxel 79 mg/m2 + carboplatin 470mg + 5FU 2415.7 mg/m2 | Progression of Disease on CT/PET | |
| Case 3 | 5- 12 | 60-66 pre 24 post | Docetaxel 75 mg/m2 | See PSA Graph |
| Case 4 | 6 | 48 pre 24 post | Docetaxel 75mg/m2 + carboplatin 540mg | Stable disease CT/PET refer to text |
| Case 5 | 2 | 36 pre | Carboplatin 480 mg + Paclitaxel 280 mg | --- |
| 3-4 | 60 pre | Carboplatin 480 mg + Paclitaxel 280 mg | 87% decline in CA 125, Reduction in lymph nodes on CT | |
| 5-6 | 60 pre 24post | Carboplatin 480 mg + Paclitaxel 280 mg | ||
| Case 6 | 3 | 62 pre 24post | Gemcitabine 720 mg/m2 (day1)+ GMZ 720 mg/m2 Docetaxel 80 mg/m2 (Day8) | --- |
| 4 | 62 pre 24post | Gemcitabine 720 mg/m2 (day1)+ GMZ 720 mg/m2 Docetaxel 80 mg/m2 (Day8) | --- | |
| 5-6 | 62 pre 24post | Gemcitabine 900 mg/m2 (day1)+ GMZ 900 mg/m2 Docetaxel 100 mg/m2 (Day8) | Stable disease on PET scan, No new MTS. | |
| Case 7 | 1 | 65 pre 8 post | Docetaxel 60 mg/m2 | See PSA Graph |
| 2-8 | 65 pre 25post*^ | Docetaxel 75 mg/m2 | See PSA Graph | |
| Case 8 | 1-4 | 64 pre 24 post** | Docetaxel 75 mg/m2 + Cyclophosphamide 600 mg/m2 | n/a |
| Case 9 | 1 | 48 pre | Doxorubicin 110 mg + Cyclophosphamide 1100 mg | n/a |
| 2-4 | 61 pre 4 post | Doxorubicin 110 mg + Cyclophosphamide 1100 mg | n/a | |
| Case 10 | 1 | 60 pre | Docetaxel 75 mg/m2 + Carboplatin 400mg | n/a |
| 2 | 48 pre | Docetaxel 75 mg/m2 + carboplatin 400mg | n/a | |
| 3 | 40 pre 24post | Docetaxel 75 mg/m2 + carboplatin 400mg | n/a | |
| 4 | 48 pre 24post | Docetaxel 75 mg/m2 + carboplatin 400mg | n/a | |
| 5 | 36 pre 24post | Docetaxel 75 mg/m2 + carboplatin 400mg | n/a | |
| 6 | 20 pre 20post | Docetaxel 75 mg/m2 + carboplatin 400mg | n/a |